20 rue Laffitte
Pharm-Olam is a mid-size global CRO with offices in 29 countries and coverage in over 40 countries worldwide. Established in 1994 and still privately owned today by our founder Dr. Zev Munk. Pharm-Olam is a stable and successful company and we continue to grow organically at double digit growth.
Local Knowledge: In many exciting emerging markets, we achieve aggressive start-up and recruitment goals that no one else can offer.
Highly Innovative: Planning ahead to access new patient populations, assigning a dedicated data project manager on every study or using technology to efficiently manage and co-ordinate our decentralized model are just a few examples of methods that Pharm-Olam implements with quality.
Inherently Flexible: Adapting quickly when the customer or trial requires processes that differ from traditional practices allows clients to achieve their goals more easily.
Tags: Phase 1, étude post-inscription, études épidémiologiques, Phase 2, Phase 3, Phase 4, Etudes de marché, Marquage CE, Rédaction médicale, Gestion de projet, Monitoring sur site, Monitoring central, TECs, Data Management, Statistiques, Expertise Méthodologique, Audit, Gestion de la pharmacovigilance, Formation investigateurs, Médicament, Dispositif Médical, Biotechnologies